NICE-recommended Device Trial UnderwayAdis International Limited (now part of Wolters Kluwer Health)Adis International Limited (now part of Wolters Kluwer Health)2012DOI 10.2165/00151234-201206610-00004
AKIGUARD (Acute Kidney Injury GUARding Device) trialUsmiani, TullioOvid Technologies (Wolters Kluwer) - Italian Federation of Cardiology2016DOI 10.2459/jcm.0000000000000348
Clinical Device Trial Opportunities for HTM ProfessionalsSchoener, BradAllen Press Online Publishing2019DOI 10.2345/0899-8205-53.1.44
Bias in a Prehospital Esophageal Detector Device Trial: Lessons LearnedVerbeek, P. RichardCambridge University Press2000DOI 10.1017/s1481803500004875
Regulatory Controversy on the Pediatric Ventricular Assist Device Trial in JapanNakada, HarukaElsevier Science2016DOI 10.1016/j.healun.2015.10.005
FDA Sees Progress in Device Trial Harmonization Effort With Japan&NAJournal of Clinical Engineering2007DOI 10.1097/01.jce.0000269291.62205.89
Assessing Learning Effects and Nonrandom Dropout in a Contraceptive Device TrialChen, Pai-LienTaylor and Francis Group2008DOI 10.1080/10543400701697232
Multicenter USA Amplatzer Patent Ductus Arteriosus Occlusion Device Trial: Initial and One-year ResultsR.H. PassElsevier Science2004DOI 10.1016/j.accreview.2004.08.093
Reducing Needlestick Injuries from Active Safety Devices: A Passive Safety-Engineered Device TrialGoris, Ashleigh J.Elsevier Science2013DOI 10.1016/j.ajic.2013.03.170
Blinding Strategies in the Conduct and Reporting of a Randomized Placebo-controlled Device TrialHouweling, A. H.SAGE Publications2014DOI 10.1177/1740774514535999
Abstract No. 43 Final Results of the GPX Embolic Device Trial for Distal Penetration ApplicationsJ. JonesElsevier BV2023DOI 10.1016/j.jvir.2022.12.085
Multicenter USA Amplatzer Patent Ductus Arteriosus Occlusion Device Trial: Initial and One-Year ResultsRobert H. PassElsevier Science2004DOI 10.1016/j.jacc.2004.03.074